Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446–54.

Article  CAS  PubMed  Google Scholar 

Camidge DR, Doebele RC, Kerr KM. Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC. Nat Rev Clin Oncol. 2019;16:341–55.

Article  CAS  PubMed  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33.

Article  PubMed  Google Scholar 

Wang K, Chen Q, Shao Y, Yin S, Liu C, Liu Y, Wang R, Wang T, Qiu Y, Yu H. Anticancer activities of TCM and their active components against tumor metastasis. Biomed Pharmacother. 2021;133: 111044.

Article  CAS  PubMed  Google Scholar 

Rodrigues T, Reker D, Schneider P, Schneider G. Counting on natural products for drug design. Nat Chem. 2016;8:531–41.

Article  CAS  PubMed  Google Scholar 

Zhang XW, Liu W, Jiang HL, Mao B. Chinese herbal medicine for advanced non-small-cell lung cancer: a systematic review and meta-analysis. Am J Chin Med. 2018;46:923–52.

Article  CAS  PubMed  Google Scholar 

Ni X, Jiang X, Yu S, Wu F, Zhou J, Mao D, Wang H, Liu Y, Jin F. Triptonodiol, a Diterpenoid extracted from tripterygium wilfordii, inhibits the migration and invasion of non-small-cell lung cancer. Molecules. 2023. https://doi.org/10.3390/molecules28124708.

Article  PubMed  PubMed Central  Google Scholar 

Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, et al. PubChem 2019 update: improved access to chemical data. Nucl Acids Res. 2019;47:D1102–9.

Article  PubMed  Google Scholar 

Gfeller D, Grosdidier A, Wirth M, Daina A, Michielin O, Zoete V. Swiss target prediction: a web server for target prediction of bioactive small molecules. Nucl Acids Res. 2014;42:W32–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucl Acids Res. 2021;49:D605–12.

Article  CAS  PubMed  Google Scholar 

Shi L, Han X, Li JX, Liao YT, Kou FS, Wang ZB, Shi R, Zhao XJ, Sun ZM, Hao Y. Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses. World J Gastroenterol. 2020;26:5983–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng JL, Xu YH, Wang G. Identification of potential crucial genes and key pathways in breast cancer using bioinformatic analysis. Front Genet. 2019;10:695.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.

Article  CAS  PubMed  Google Scholar 

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hsin KY, Ghosh S, Kitano H. Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology. PLoS ONE. 2013;8: e83922.

Article  PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD, Jemal A. cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.

Article  PubMed  Google Scholar 

Wang Y, Zhang X, Wang Y, Zhao W, Li H, Zhang L, Li X, Zhang T, Zhang H, Huang H, et al. Application of immune checkpoint targets in the anti-tumor novel drugs and traditional Chinese medicine development. Acta Pharm Sin B. 2021;11:2957–72.

Article  PubMed  PubMed Central  Google Scholar 

Nacher JC, Schwartz JM. A global view of drug-therapy interactions. BMC Pharmacol. 2008;8:5.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Mao X, Li W, Chen W, Wang X, Ma Z, Lin N. Tripterygium wilfordii: an inspiring resource for rheumatoid arthritis treatment. Med Res Rev. 2021;41:1337–74.

Article  PubMed  Google Scholar 

Xu Q, Bauer R, Hendry BM, Fan TP, Zhao Z, Duez P, Simmonds MS, Witt CM, Lu A, Robinson N, et al. The quest for modernisation of traditional Chinese medicine. BMC Complement Altern Med. 2013;13:132.

Article  PubMed  PubMed Central  Google Scholar 

Wang XQ, Zhang Y, Hou W, Wang YT, Zheng JB, Li J, Lin LZ, Jiang YL, Wang SY, Xie Y, et al. association between Chinese medicine therapy and survival outcomes in postoperative patients with NSCLC: a multicenter, prospective. Cohort Study Chin J Integr Med. 2019;25:812–9.

Article  CAS  PubMed  Google Scholar 

Wang J, Wong YK, Liao F. What has traditional Chinese medicine delivered for modern medicine? Expert Rev Mol Med. 2018;20: e4.

Article  PubMed  Google Scholar 

Stambolic V, Woodgett JR. Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J. 1994;303(Pt 3):701–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sutherland C, Cohen P. The alpha-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro. FEBS Lett. 1994;338:37–42.

Article  CAS  PubMed  Google Scholar 

Sutherland C, Leighton IA, Cohen P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J. 1993;296(Pt 1):15–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal. 2014;7:re8.

Article  PubMed  PubMed Central  Google Scholar 

Kazi A, Xiang S, Yang H, Delitto D, Trevino J, Jiang R, Ayaz M, Lawrence HR, Kennedy P, Sebti SM. GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors. Nat Commun. 2018;9:5154.

Article  PubMed  PubMed Central  Google Scholar 

Tian Y, Li P, Xiao Z, Zhou J, Xue X, Jiang N, Peng C, Wu L, Tian H, Popper H, et al. Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k/GSK3/β-catenin signaling pathway in taxol-resistant human lung adenocarcinoma. Transl Lung Cancer Res. 2021;10:1007–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arteaga CL, Engelman JA. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. Cancer Cell. 2014;25:282–303.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prickett TD, Agrawal NS, Wei X, Yates KE, Lin JC, Wunderlich JR, Cronin JC, Cruz P, Rosenberg SA, Samuels Y. Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4. Nat Genet. 2009;41:1127–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kobayashi S, Boggon TJ, Dayaram T, Jänne PA, Kocher O, Meyerson M, Johnson BE, Eck MJ, Tenen DG, Halmos B. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med. 2005;352:786–92.

Article  CAS  PubMed  Google Scholar 

Pao W, Miller VA, Politi KA, Riely GJ, Somwar R, Zakowski MF, Kris MG, Varmus H. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med. 2005;2: e73.

Article  PubMed  PubMed Central  Google Scholar 

Montagut C, Dalmases A, Bellosillo B, Crespo M, Pairet S, Iglesias M, Salido M, Gallen M, Marsters S, Tsai SP, et al. Identification of a mutation in the extracellular domain of the epidermal growth factor receptor conferring cetuximab resistance in colorectal cancer. Nat Med. 2012;18:221–3.

Article  CAS  PubMed